Yusuf Cem Kaplan

ORCID: 0000-0003-0369-7934
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and Medication Impact
  • Pharmacological Effects and Toxicity Studies
  • Maternal Mental Health During Pregnancy and Postpartum
  • Pregnancy and preeclampsia studies
  • Reproductive Health and Contraception
  • Epilepsy research and treatment
  • Ovarian function and disorders
  • Breastfeeding Practices and Influences
  • Birth, Development, and Health
  • Forensic Toxicology and Drug Analysis
  • Endometriosis Research and Treatment
  • Neonatal Respiratory Health Research
  • Uterine Myomas and Treatments
  • Child and Adolescent Psychosocial and Emotional Development
  • Child and Adolescent Health
  • Reproductive System and Pregnancy
  • Cardiovascular Issues in Pregnancy
  • Assisted Reproductive Technology and Twin Pregnancy
  • Nausea and vomiting management
  • Poisoning and overdose treatments
  • Electrolyte and hormonal disorders
  • Pharmaceutical studies and practices
  • Livestock Management and Performance Improvement
  • Acne and Rosacea Treatments and Effects
  • Genetic and phenotypic traits in livestock

Izmir Kâtip Çelebi University
2015-2024

İzmir University of Economics
2012-2023

General Directorate of Agricultural Research and Policies
2023

University of Westminster
2021

University of Southern Denmark
2020

Misr University for Science and Technology
2018

Kahramanmaraş Sütçü İmam University
2017

University of Toronto
2015-2016

Hospital for Sick Children
2015-2016

SickKids Foundation
2015-2016

Abstract Despite the extensive amount of academic work devoted to supply chain management, today structure service chains still remains unexplored. The aim this paper is verify and explain gap with regard unique nature services industry applicability existing management literature businesses. This develops a new model for applies it healthcare industry. results study are relevant both practitioners in researchers conducting further studies field. Notes 1. http://www.supply-chain.org....

10.1080/02642060601122629 article EN Service Industries Journal 2007-03-01

Aims Metformin is used to treat type 2 diabetes, polycystic ovary syndrome associated infertility, and gestational diabetes. This study aims evaluate the safety of metformin in early pregnancy. Method We evaluated risk major birth defects pregnancy losses a cohort pregnant women exposed during first trimester for different indications relative matched unexposed reference group. Results The was 5.1% (20/392) pregnancies 2.1% (9/431) group [adjusted odds ratio (OR) 1.70; 95% CI 0.70–4.38]....

10.1111/bcp.13481 article EN British Journal of Clinical Pharmacology 2017-12-07

This multicenter, observational prospective cohort study addresses the risk associated with exposure to mirtazapine during pregnancy. Pregnancy outcomes after were compared 2 matched control groups: (1) any selective serotonin reuptake inhibitor (SSRI, subjects a psychiatric condition) and (2) no medication known be teratogenic or antidepressant (general subjects). Data collected by members of European Network Teratology Information Services between 1995 2011. Observations from 357 exposed...

10.1097/jcp.0000000000000309 article EN Journal of Clinical Psychopharmacology 2015-04-03

Abstract Garlic has long been used for medicinal purposes. It shown that different forms of garlic have significant antioxidant effects. The strong flavor, odor and unwanted gastrointestinal side effects fresh rendered the use commercial supplements as a preferable option. To investigate supplementation on serum total capacity lipid parameters, 17 healthy volunteers were administered four standardized tablets every day 30 days. Blood samples taken at 1 (before first administration [control]...

10.1002/ptr.2953 article EN Phytotherapy Research 2009-08-03

This prospective multicentre cohort study investigated pregnancy outcomes after fingolimod use for multiple sclerosis during pregnancy. Pregnancy of 63 and 62 interferon-β-exposed pregnancies were compared. Rates major congenital anomalies (MCA) 4.8% (2/42) in the group versus 2.3% (1/44) interferon-β (odds ratio, 2.2; 95% confidence interval, 0.2–24.6). The adjusted hazard ratio spontaneous abortion was 0.6 (95% 0.2–1.8). Further studies are needed to definitely rule out a moderately...

10.1177/1352458520929628 article EN Multiple Sclerosis Journal 2020-06-15

Background Reproductive health conditions such as endometriosis, uterine fibroids, and polycystic ovary syndrome (PCOS) affect a large proportion of women people who menstruate worldwide. Prevalence estimates for these range from 5% to 40% reproductive age. Long diagnostic delays, up 12 years, are common contribute complications increased care costs. Symptom checker apps provide users with information tools better understand their symptoms thus have the potential reduce time diagnosis...

10.2196/46718 article EN cc-by JMIR mhealth and uhealth 2023-11-08

The aim of this study was to investigate the effect glucagon on cardiovascular parameters in anesthetized rat model tricyclic antidepressant overdose. Toxicity induced by infusion amitriptyline 0.94 mg/kg/min until a 40–45% reduction mean arterial pressure observed. Amitriptyline rats were then randomized into three groups. Control group (group 1) received bolus 5% dextrose followed continuous dextrose, whereas treatment groups 1 mg/kg 2) or 2 3) doses (0.1 mg/kg/min) glucagons for 60 min....

10.1177/0960327108092289 article EN Human & Experimental Toxicology 2008-04-01

This case report describes a false-positive amphetamine/ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] and ecstasy (MDMA) screen after therapeutic use of antihyperlipidemic drug, fenofibrate. A 60-year-old male patient was admitted to inpatient psychiatry unit with the diagnosis alcohol dependency. He prescribed diazepam 30 mg/day, thiamine 300 naltrexone 50 mg/day. had also been using fenofibrate 267 mg/day for 3 years hyperlipidemia trazodone 100 5 months insomnia. On routine, urine...

10.1097/ftd.0b013e3182690127. article EN Therapeutic Drug Monitoring 2012-09-12

To the best of our knowledge this is first case report describing exposure to varenicline, an α 4 β 2 nicotinic acetylcholine partial receptor agonist used for smoking cessation therapy in pregnancy. A 29-year-old multiparous woman with unplanned pregnancy has varenicline mg/day unintentionally yet regularly weeks from her last menstrual period. Fetal ultrasound performed at each trimester, detailed anomaly scan, and fetal echocardiography which were 22nd gestational week showed normal...

10.1155/2014/263981 article EN cc-by Case Reports in Obstetrics and Gynecology 2014-01-01
Coming Soon ...